XML 45 R35.htm IDEA: XBRL DOCUMENT v3.8.0.1
Research and License Agreements - Additional Information (Detail)
1 Months Ended 3 Months Ended
Jun. 30, 2015
USD ($)
May 31, 2014
USD ($)
Oct. 31, 2011
USD ($)
item
Mar. 31, 2018
USD ($)
item
Mar. 31, 2017
USD ($)
Research and License Agreements          
Revenue $ 20,000,000 $ 15,000,000  
Number of milestones included in transaction price | item       0  
License Agreement | Pfizer          
Research and License Agreements          
Up-front payment received     $ 22,500,000    
Revenue       $ 0 0
Transaction price       22,500,000  
Research Services Agreement | University Of Basel          
Research and License Agreements          
Milestone payment obligation       $ 0 $ 0
Royalty payment due against license fees received (as a percent)       10.00%  
Achievement Of Specified Development Milestone | License Agreement | Pfizer          
Research and License Agreements          
Non-refundable milestone payment received $ 20,000,000 $ 15,000,000      
Achievement Of Specified Development Milestone | License Agreement | Pfizer | Maximum          
Research and License Agreements          
Potential milestone payments     $ 115,000,000    
Number of indications | item     2    
Achievement Of Specified Regulatory Milestone | License Agreement | Pfizer | Maximum          
Research and License Agreements          
Potential milestone payments     $ 70,000,000    
Number of indications | item     2    
Achievement Of Specified Levels Of Annual Net Sales Of Licensed Products | License Agreement | Pfizer | Maximum          
Research and License Agreements          
Potential milestone payments     $ 135,000,000